- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Invar
Pharmaceutical Executive
Foreign player? Choose a local partner
For a Western company looking to enter the Russian market, the question of how best to capture value is daunting, especially if they go it alone. This is true for not only pharmaceutical but also biopharmaceutical enterprises, whose era is just now evolving in Russia.
Invar, a Russian company with over 20 years of experience in pharmaceutical partnership, builds their business model around strategic alliances with owners of innovative products. As Invar's capabilities and experience in this field grew, the company expanded services to partner with large and medium-sized organizations, and helps them to promote their portfolio or future pipeline in Russia. This year, Invar announced its expansion into the area of biopharmaceuticals.
Ralf Vayntrub, company president, observes, "In Russia, we are living through a period of intense changes on the pharmaceutical market. Nonetheless, the majority of the transformations this industry is undergoing are positive, and interest in the market is growing.
To capitalize on the growth and transformation of the market, Western players need a partner who understands the local environment. In order to capture a piece of this pie, they need a quality, Russian player to collaborate with. We are very much open to such collaboration with new partners."
The Transformative Role of Medical Information in Customer Engagement
October 3rd 2024Stacey Fung, Head of Global Medical Information at Gilead Lifesciences, delves into the evolving role of Medical Information (MI) in the pharmaceutical industry. Covering key topics like patient engagement through omnichannel strategies, combating misinformation, and leveraging AI to enhance medical inquiries, the conversation with Stacey highlights MI's critical role in ensuring patient safety and supporting drug development. She also shares her professional journey and tidbits for early career professionals on professional development.
Unlocking value and cost savings in patient services with technology and talent
October 2nd 2024Traci Miller, Director, Sonexus™ Access and Patient Support, Cardinal Health, discusses the current digital trends in the patient services industry and how the optimal balance of technology and talent can transform manufacturer-sponsored patient support programs. Hear how Cardinal Health combines best-in-class program and pharmacy operations with smart digital tools to ensure product and patient success and reduce operational costs.
